• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number ATG120184
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Codes No Consequences Or Impact To Patient (2199); Injury (2348)
Date of Event 11/30/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiry date: 04/2021).The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that during an angioplasty procedure in the superior vena cava, the pta balloon was allegedly found to be detached.A snare was used to retrieve the detached material, via an alternate access site.No further treatment was needed.There was no reported patient injury.
 
Event or Problem Description
It was reported that during an angioplasty procedure in the superior vena cava, the pta balloon was allegedly found to be detached.A snare was used to retrieve the detached material, via an alternate access site.No further treatment was needed.There was no reported patient injury.
 
Additional Manufacturer Narrative
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the balloon of the device was returned for evaluation.The catheter and hub was not returned.The balloon segment was examined and signs of detachment were noted at both balloon weld locations.Therefore, the investigation is confirmed for balloon detachment.The definitive root cause for the identified detachment could not be determined based upon available information.It is unknown whether procedural issues contributed to the event.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.(expiry date: 04/2021).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATLAS GOLD PTA DILATATION CATHETER
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8337526
Report Number2020394-2019-00123
Device Sequence Number1691986
Product Code LIT
UDI-Device Identifier00801741060885
UDI-Public(01)00801741060885
Combination Product (Y/N)N
Initial Reporter CountrySP
PMA/510(K) Number
K181323
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberATG120184
Device Catalogue NumberATG120184
Device Lot Number93PC0084
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/25/2019
Initial Date Received by Manufacturer 01/17/2019
Supplement Date Received by Manufacturer05/08/2019
Initial Report FDA Received Date02/13/2019
Supplement Report FDA Received Date05/13/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age57 YR
Patient Weight72
-
-